Briviact Description

Film-coated tablet (25 mg): Grey, oval, with dimensions of 8.9 mm x 5.0 mm, debossed with 'u25' on one side.
Each film-coated tablet contains 25 mg brivaracetam.
Excipient(s) with known effect: Each 25 mg film-coated tablet contains 94 mg lactose.
Excipients/Inactive Ingredients: Core: Croscarmellose sodium, Lactose monohydrate, Betadex, Lactose anhydrous, Magnesium stearate.
Coating: Poly(vinyl alcohol), Titanium dioxide (E171), Macrogol (3350), Talc, Iron oxide yellow (E172), Iron oxide black (E172).
Film-coated tablet (50 mg): Yellow, oval, with dimensions of 11.7 mm x 6.6 mm, debossed with 'u50' on one side.
Each film-coated tablet contains 50 mg brivaracetam.
Excipient(s) with known effect: Each 50 mg film-coated tablet contains 189 mg lactose.
Excipients/Inactive Ingredients: Core: Croscarmellose sodium, Lactose monohydrate, Betadex, Lactose anhydrous, Magnesium stearate.
Coating: Poly(vinyl alcohol), Titanium dioxide (E171), Macrogol (3350), Talc, Iron oxide yellow (E172), Iron oxide red (E172).
Film-coated tablet (100 mg): Green-grey, oval, with dimensions of 14.5 mm x 8.1 mm, debossed with 'u100' on one side.
Each film-coated tablet contains 100 mg brivaracetam.
Excipient(s) with known effect: Each 100 mg film-coated tablet contains 377 mg lactose.
Excipients/Inactive Ingredients: Core: Croscarmellose sodium, Lactose monohydrate, Betadex, Lactose anhydrous, Magnesium stearate.
Coating: Poly(vinyl alcohol), Titanium dioxide (E171), Macrogol (3350), Talc, Iron oxide yellow (E172), Iron oxide black (E172).
Oral solution: Slightly viscous, clear colourless to yellowish liquid.
Each ml contains 10 mg brivaracetam.
Excipient(s) with known effect: Each ml of oral solution contains 239.8 mg sorbitol (E420), 1 mg methyl parahydroxybenzoate (E218) and 1.16 mg sodium.
Excipients/Inactive Ingredients: Sodium citrate, Citric acid anhydrous (for pH-adjustment), Methyl parahydroxybenzoate (E218), Carmellose sodium, Sucralose, Sorbitol liquid, Glycerol (E422), Raspberry flavour (propylene glycol 90% - 98%), Purified water.
Solution for injection/infusion: Clear, colourless solution.
Each ml contains 10 mg brivaracetam.
Each 5 ml vial contains 50 mg brivaracetam.
Excipient(s) with known effect: Each ml of solution for injection/infusion contains 3.8 mg sodium.
Excipients/Inactive Ingredients: Sodium acetate (trihydrate), Glacial acetic acid (for pH-adjustment), Sodium chloride, Water for injections.